S. Murphy

ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors.

G. MacBeath, N. Cheung, A. Boudot, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Novel tetravalent bispecific T-cell engaging antibodies for cancer immunotherapy.

S. Murphy, S. Lakshmikanthan, T. Wyant, 2019, Journal of Clinical Oncology.

Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency.

S. Murphy, J. Githens, D. Ambruso, 1982, The Journal of pediatrics.